Abstract:Aims/Purpose: Microglia‐mediated neuroinflammation is involved in many neurodegenerative diseases, including glaucoma and diabetic retinopathy. This study examined the effects of anti‐cytokine antibodies on LPS‐induced inflammatory response of microglial cells, and explored the underlying molecular mechanisms by proteomic analysis. Methods: A lipopolysaccharide (LPS)‐induced neuroinflammation model was established in murine BV‐2 microglial cells in vitro. The expression of microglial cell markers (CD68 and CD206) were detected by immunocytochemistry. BV‐2 was stimulated with LPS (1 μg/mL) with or without anti‐tumour necrosis factor‐alpha (anti‐TNF‐α, 2 μg /ml) or anti‐interleukin‐1 beta (anti‐IL‐1β, 4 μg /ml) for 24 h. LPS‐induced inflammation level was analysed using the Griess assay to determine nitric oxide (NO) concentration. Proteome alterations were characterized employing the mass spectrometry‐based proteomics and bioinformatics analyses. Results: Immunocytochemistry confirmed the expression of microglial markers in BV‐2 cells. LPS stimulation induced excessive activation of BV‐2, with significant increase in NO generation ( p < 0.0001). Anti‐IL‐1β significantly attenuated 34% of the LPS‐induced NO generation ( p < 0.0001). Interestingly, anti‐TNF‐α showed a stronger anti‐inflammatory effect by reducing 57% of LPS‐induced NO generation ( p < 0.0001). Bioinformatics analyses revealed that differentially expressed proteins involved in inflammation ( p = 3.8 × 10 −5 ) and apoptotic ( p = 3.2 × 10 −11 ) signalling pathways were significantly activated by LPS. Particularly, LPS‐mediated upregulation of STAT1 ( p = 8.6 × 10 −6 ) was restored by anti‐IL‐1β and anti‐TNF‐α ( p = 3.1 × 10 −4 and p = 2.7 × 10 −3 , respectively). Anti‐IL‐1β induced proteome alterations involved in anti‐inflammatory signalling pathways and promote glial cell polarization towards neuroprotective M2 phenotype ( p = 5.3 × 10 −6 ), while anti‐TNF‐α treatment significantly regulated proteins involved in immune response of macrophages ( p = 2.7 × 10 −8 ). Conclusions: In summary, anti‐TNF‐α and anti‐IL‐1β antibodies alleviated LPS‐induced neuroinflammation and altered proteins involved in neuroprotective pathways. Hence, anti‐cytokine antibodies have therapeutic potential as neuroprotective agents.

Protosappanin A Exerts Anti-Neuroinflammatory Effect by Inhibiting JAK2-STAT3 Pathway in Lipopolysaccharide-Induced BV2 Microglia.

C16 Peptide and Angiopoietin-1 Protect Against LPS-induced BV-2 Microglial Cell Inflammation.

Sinapic Acid Attenuates the Neuroinflammatory Response by Targeting AKT and MAPK in LPS-Activated Microglial Models

Ampelopsin Attenuates Lipopolysaccharide-Induced Inflammatory Response Through the Inhibition of the NF-κB and JAK2/STAT3 Signaling Pathways in Microglia.

Baicalin Mitigates the Neuroinflammation through the TLR4/MyD88/NF-κB and MAPK Pathways in LPS-Stimulated BV-2 Microglia

The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells

Polydatin inhibits LPS-induced inflammatory response in BV2 microglia by disrupting the formation of lipid rafts

Piceatannol Protects Brain Endothelial Cell Line (bEnd.3) against Lipopolysaccharide-Induced Inflammation and Oxidative Stress

ω-3 DPA Protected Neurons from Neuroinflammation by Balancing Microglia M1/M2 Polarizations through Inhibiting NF-κB/MAPK p38 Signaling and Activating Neuron-BDNF-PI3K/AKT Pathways

Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway

Malonic acid suppresses lipopolysaccharide-induced BV2 microglia cell activation by inhibiting the p38 MAPK/NF-κB pathway

Baicalin Ameliorates Cognitive Impairment and Protects Microglia from LPS-Induced Neuroinflammation Via the SIRT1/HMGB1 Pathway

Deoxysappanone B, a homoisoflavone from the Chinese medicinal plant Caesalpinia sappan L., protects neurons from microglia-mediated inflammatory injuries via inhibition of IκB kinase (IKK)-NF-κB and p38/ERK MAPK pathways.

The attenuating effects of 1,2,3,4,6 Penta‐o‐Galloyl‐β‐D‐Glucose on the inflammatory cytokines release from activated BV‐2 microglial cells

Vanillic Acid, a Bioactive Phenolic Compound, Counteracts LPS-Induced Neurotoxicity by Regulating c-Jun N-Terminal Kinase in Mouse Brain

Protosappanin A Maintains Neuronal Mitochondrial Homeostasis Through Promoting Autophagic Degradation of Bax

Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons

Trans-Cinnamaldehyde Inhibits Microglial Activation and Improves Neuronal Survival Against Neuroinflammation in BV2 Microglial Cells with Lipopolysaccharide Stimulation

SIRT1 activation by 2,3,5,6-tetramethylpyrazine alleviates neuroinflammation via inhibiting M1 microglia polarization

Potential neuroprotective effects of anti‐cytokine antibodies against lipopolysaccharide‐induced microglial inflammation

Dalesconols B Inhibits Lipopolysaccharide Induced Inflammation and Suppresses NF-κB and P38/jnk Activation in Microglial Cells